Addus HomeCare (NASDAQ:ADUS) Shares Down 6.1% – Should You Sell?

Addus HomeCare Co. (NASDAQ:ADUS)’s stock price dropped 6.1% during mid-day trading on Tuesday . The company traded as low as $117.27 and last traded at $121.10. Approximately 21,713 shares were traded during mid-day trading, a decline of 83% from the average daily volume of 130,611 shares. The stock had previously closed at $128.96.

Wall Street Analyst Weigh In

ADUS has been the topic of several analyst reports. Stephens reissued an “overweight” rating and issued a $138.00 target price on shares of Addus HomeCare in a research note on Tuesday, August 6th. Macquarie restated an “outperform” rating and set a $139.00 price objective on shares of Addus HomeCare in a report on Monday. Royal Bank of Canada restated an “outperform” rating and issued a $141.00 price target on shares of Addus HomeCare in a report on Tuesday, September 3rd. KeyCorp initiated coverage on Addus HomeCare in a report on Friday, October 11th. They set an “overweight” rating and a $150.00 target price for the company. Finally, Oppenheimer raised their target price on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research report on Monday, September 23rd. One research analyst has rated the stock with a sell rating, eight have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $131.38.

Addus HomeCare Stock Performance

The company has a fifty day moving average of $129.93 and a two-hundred day moving average of $120.66. The firm has a market capitalization of $2.27 billion, a price-to-earnings ratio of 28.13, a PEG ratio of 2.29 and a beta of 1.04.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. Addus HomeCare had a net margin of 6.18% and a return on equity of 9.81%. The business had revenue of $289.80 million for the quarter, compared to analyst estimates of $289.42 million. During the same period last year, the firm earned $1.03 earnings per share. Addus HomeCare’s revenue for the quarter was up 7.1% compared to the same quarter last year. Equities analysts forecast that Addus HomeCare Co. will post 4.57 EPS for the current year.

Insider Activity at Addus HomeCare

In related news, Director Esteban Lopez sold 500 shares of the firm’s stock in a transaction on Wednesday, September 4th. The stock was sold at an average price of $130.03, for a total transaction of $65,015.00. Following the completion of the transaction, the director now directly owns 3,866 shares of the company’s stock, valued at $502,695.98. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other news, EVP Michael D. Wattenbarger sold 21,917 shares of Addus HomeCare stock in a transaction on Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the completion of the sale, the executive vice president now owns 7,215 shares in the company, valued at $961,687.35. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Esteban Lopez sold 500 shares of the stock in a transaction on Wednesday, September 4th. The stock was sold at an average price of $130.03, for a total transaction of $65,015.00. Following the transaction, the director now directly owns 3,866 shares in the company, valued at approximately $502,695.98. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 22,917 shares of company stock valued at $3,050,082. 4.60% of the stock is owned by insiders.

Hedge Funds Weigh In On Addus HomeCare

A number of hedge funds have recently added to or reduced their stakes in the stock. Point72 Asset Management L.P. boosted its stake in Addus HomeCare by 73.4% in the second quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock valued at $86,598,000 after acquiring an additional 315,602 shares during the last quarter. Millennium Management LLC lifted its stake in Addus HomeCare by 412.7% in the second quarter. Millennium Management LLC now owns 316,418 shares of the company’s stock valued at $36,739,000 after purchasing an additional 254,705 shares during the last quarter. Boston Partners bought a new position in Addus HomeCare during the first quarter valued at $12,215,000. Ghisallo Capital Management LLC purchased a new stake in Addus HomeCare in the second quarter worth $11,611,000. Finally, Lord Abbett & CO. LLC bought a new stake in shares of Addus HomeCare in the first quarter valued at $8,274,000. Institutional investors and hedge funds own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.